Sonavex
2013
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A1
LATEST DEAL TYPE
$3M
LATEST DEAL AMOUNT
24
INVESTORS
Description
Developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling clinicians to measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes.
Website
Formerly Known As
Veridian Surgical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
- 2835 O'Donnell Street
- Suite 200
- Baltimore, MD 21224
- United States
+1 (443) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Sonavex’s full profile, request a free trial.
Sonavex Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series A1) | 05-Nov-2019 | $3M | 00.000 | 0000 | Completed | Generating Revenue |
| 11. Grant | 29-Aug-2019 | 000 | 00.000 | Completed | Generating Revenue | |
| 10. Early Stage VC (Series A) | 01-Dec-2017 | 00.00 | 00.000 | 000.00 | Completed | Generating Revenue |
| 9. Accelerator/Incubator | 07-Aug-2017 | 00000 | Completed | Generating Revenue | ||
| 8. Grant | 24-Apr-2017 | 00000 | 00000 | Completed | Generating Revenue | |
| 7. Grant | 01-May-2016 | 00000 | 00000 | Completed | Generating Revenue | |
| 6. Seed Round | 19-Sep-2015 | 00000 | 00000 | 00.000 | Completed | Generating Revenue |
| 5. Grant | 06-Sep-2015 | 00000 | Completed | Generating Revenue | ||
| 4. Grant | 30-Jun-2015 | $180K | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 12-Dec-2014 | Completed | Generating Revenue |
Sonavex Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Series A | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Seed | 140,464 | $0.000100 | $2.37 | $2.37 | 1x | $2.37 | 6.7% |
Sonavex Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xoran Technologies | Private Equity-Backed | Ann Arbor, MI | 00 | 000 | 0000000 0000 | 000 |
| 00000 0000000 | Venture Capital-Backed | Markham, Canada | 00 | 000.00 | 0000000000 0 | 000.00 |
| 0000000000 0000000 | Corporate Backed or Acquired | Brønshøj, Denmark | 0000 | 000000&0 |
Sonavex Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| ChinaRock Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| FundRx | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Fusion Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Grey Sky Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Houston Angel Network | Angel Group | Minority | 000 0000 | 000000 0 |
Sonavex Executive Team (5)
1 Former Executive
You’re viewing 4 of 5 executives. Get the full list »Sonavex Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Bob Hallenbeck | Self | Board Member | 000 0000 | |
| David Narrow | Sonavex | Co-Founder, Chief Executive Officer & Board Member | 000 0000 | |
| Devin O'Brien-Coon MD | Sonavex | Co-Founder, President, Chief Medical Officer & Chairman | 000 0000 | |
| Jerry Prince Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
| William Niland | Self | Board Member | 000 0000 |